Rowlandmiller & Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3M Sell
64,152
-494
-0.8% -$115K 2.97% 9
2026
Q1
$15.8M Sell
64,646
-1,321
-2% -$308K 3.2% 6
2025
Q4
$13.7M Sell
65,967
-297
-0.4% -$58.7K 2.63% 9
2025
Q3
$12.3M Sell
66,264
-3,086
-4% -$529K 2.41% 10
2025
Q2
$10.6M Sell
69,350
-175
-0.3% -$26.9K 2.19% 12
2025
Q1
$11.5M Sell
69,525
-669
-1% -$105K 2.43% 10
2024
Q4
$10.2M Sell
70,194
-103
-0.1% -$16K 2.12% 13
2024
Q3
$11.4M Sell
70,297
-260
-0.4% -$41.4K 2.31% 12
2024
Q2
$10.3M Sell
70,557
-1,208
-2% -$180K 2.25% 11
2024
Q1
$11.4M Buy
71,765
+102
+0.1% +$16.2K 2.4% 12
2023
Q4
$11.2M Sell
71,663
-315
-0.4% -$48.3K 2.57% 11
2023
Q3
$11.2M Sell
71,978
-542
-0.7% -$89.4K 2.77% 7
2023
Q2
$12M Buy
72,520
+28
+0% +$4.52K 2.84% 7
2023
Q1
$11.2M Buy
72,492
+684
+1% +$110K 2.73% 7
2022
Q4
$12.8M Buy
71,808
+13
+0% +$2.25K 3.17% 5
2022
Q3
$11.7M Buy
71,795
+1,005
+1% +$170K 3.16% 5
2022
Q2
$12.6M Sell
70,790
-3
-0% -$535 3.22% 5
2022
Q1
$12.5M Sell
70,793
-463
-0.6% -$78.8K 2.91% 7
2021
Q4
$12.2M Buy
71,256
+167
+0.2% +$27.3K 2.73% 10
2021
Q3
$10M Buy
71,089
+1,107
+2% +$189K 3.39% 7
2021
Q2
$11.5M Sell
69,982
-84
-0.1% -$13.9K 2.83% 8
2021
Q1
$11.5M Sell
70,066
-1,331
-2% -$215K 3.01% 8
2020
Q4
$11.2M Sell
71,397
-465
-0.6% -$68.6K 3.2% 8
2020
Q3
$9.42M Buy
71,862
+773
+1% +$114K 3.78% 6
2020
Q2
$10M Sell
71,089
-773
-1% -$113K 3.39% 7
2020
Q1
$9.42M Sell
71,862
-560
-0.8% -$79.5K 3.78% 6
2019
Q4
$10.6M Buy
72,422
+966
+1% +$131K 3.28% 6
2019
Q3
$9.28M Sell
71,456
-733
-1% -$96.6K 3.15% 7
2019
Q2
$10M Sell
72,189
-160
-0.2% -$22.1K 3.47% 5
2019
Q1
$10.1M Buy
72,349
+102
+0.1% +$13.7K 3.62% 5
2018
Q4
$9.32M Buy
72,247
+64,301
+809% +$8.97M 3.78% 4
2018
Q3
$897K Sell
7,946
-62,600
-89% -$8.32M 0.32% 60
2018
Q2
$8.54M Buy
70,546
+153
+0.2% +$19.1K 3.32% 5
2018
Q1
$9.01M Sell
70,393
-380
-0.5% -$51.4K 3.57% 5
2017
Q4
$9.93M Buy
70,773
+121
+0.2% +$16.9K 3.89% 3
2017
Q3
$9.16M Sell
70,652
-928
-1% -$123K 3.8% 3
2017
Q2
$9.48M Sell
71,580
-1,235
-2% -$158K 4.02% 3
2017
Q1
$9.07M Buy
72,815
+186
+0.3% +$22.2K 4% 3
2016
Q4
$8.37M Sell
72,629
-24
-0% -$2.77K 3.79% 4
2016
Q3
$8.58M Sell
72,653
-1,030
-1% -$125K 3.98% 3
2016
Q2
$8.91M Sell
73,683
-1,729
-2% -$196K 4.1% 3
2016
Q1
$8.16M Buy
75,412
+252
+0.3% +$26.1K 3.86% 3
2015
Q4
$7.49M Buy
75,160
+140
+0.2% +$14.1K 3.8% 5
2015
Q3
$6.95M Sell
75,020
-306
-0.4% -$29.6K 3.68% 5
2015
Q2
$7.34M Buy
75,326
+406
+0.5% +$40.7K 3.65% 4
2015
Q1
$7.42M Sell
74,920
-186
-0.2% -$18.9K 3.69% 4
2014
Q4
$7.85M Buy
+75,106
New +$7.91M 3.81% 3

Other funds holding JNJ

Rowlandmiller & Partners's JNJ Position: Q2 2026 in Review

Rowlandmiller & Partners reduced its Johnson & Johnson (JNJ) stake by 0.76% in Q2 2026, selling an estimated $115K and leaving 64,152 shares worth $16.3M. The position accounts for 2.97% of the portfolio, ranked #9.

Rowlandmiller & Partners first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Rowlandmiller & Partners held 64,152 shares of Johnson & Johnson worth $16.3M as of Q2 2026.
  • Rowlandmiller & Partners sold 494 Johnson & Johnson shares in Q2 2026, an estimated $115K.
  • Johnson & Johnson made up 2.97% of Rowlandmiller & Partners's portfolio in Q2 2026, its #9 holding.
  • Rowlandmiller & Partners first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Rowlandmiller & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.